DailyMet GP1 Tablets

Glimepiride 1 mg, Pioglitazone 15 mg & Metformin 500 mg for Type 2 Diabetes Management

DailyMet GP1 Tablets combine Glimepiride 1 mg, Pioglitazone 15 mg, and Metformin Hydrochloride 500 mg in a triple-action formula to help manage Type 2 Diabetes Mellitus. Each ingredient works through a different mechanism to improve blood sugar control, making it an effective option for adults who require combination therapy.

Glimepiride stimulates insulin release, Metformin reduces glucose production and improves insulin sensitivity, while Pioglitazone enhances the body's response to insulin. Together, they help maintain healthy blood glucose levels when used alongside a balanced diet and regular exercise.

Key Benefits

✔ Helps manage Type 2 Diabetes Mellitus

✔ Supports effective control of high blood sugar levels

✔ Glimepiride stimulates insulin secretion from the pancreas

✔ Metformin improves insulin sensitivity and reduces glucose production

✔ Pioglitazone helps the body use insulin more effectively

✔ Supports stable blood glucose levels throughout the day

✔ Helps reduce the risk of diabetes-related complications when used as prescribed

Composition

Each tablet contains:

• Glimepiride – 1 mg

• Pioglitazone – 15 mg

• Metformin Hydrochloride – 500 mg

Who Can Benefit?

DailyMet GP1 Tablets may be prescribed for adults who:

• Have Type 2 Diabetes Mellitus

• Require triple-drug therapy for improved blood sugar control

• Have been advised by their healthcare professional to take Glimepiride, Pioglitazone, and Metformin together

How to Use

Take exactly as prescribed by your physician, preferably with meals to help reduce stomach discomfort. Continue following your recommended diet, exercise plan, and regular blood sugar monitoring.

Storage Instructions

• Store in a cool, dry place.

• Protect from direct sunlight and moisture.

• Keep out of reach of children.

Safety Information

• Use only under the supervision of a registered healthcare professional.

• Read the label carefully before use.

• Do not skip meals, as this medicine may increase the risk of low blood sugar (hypoglycemia).

• Inform your doctor if you have kidney, liver, heart, or bladder problems before using this medicine.

• Keep all medicines out of the reach of children.

Why Choose DailyMet GP1?

DailyMet GP1 combines Glimepiride, Pioglitazone, and Metformin in a clinically established triple-action formula to provide comprehensive blood sugar management for adults with Type 2 Diabetes. It helps improve insulin function, enhance glucose control, and supports long-term diabetes care under medical supervision.